发明名称 Preventing diseases in infants delivered via caesarean section
摘要 The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section.
申请公布号 US9107438(B2) 申请公布日期 2015.08.18
申请号 US201314135171 申请日期 2013.12.19
申请人 N.V. NUTRICIA 发明人 Schmitt Joachim;Stahl Bernd;Knol Jan
分类号 A23L1/29;A23C9/123;A23C9/20;A23L1/03;A23L1/30;A23L1/308;A61K31/202;A61K31/702;A61K31/7068;A61K31/7072;A61K31/7076;A61K31/708;A61K31/732;A61K31/734;A61K35/745;A61K35/747;A61K35/74;A61K47/36 主分类号 A23L1/29
代理机构 Foley & Lardner, LLP 代理人 Villacorta Gilberto M.;Talapatra Sunit;Foley & Lardner, LLP
主权项 1. A method for treatment and/or prevention of atopic dermatitis, eczema, asthma, allergic rhinitis or allergic conjunctivitis, in infants delivered via caesarean section comprising administering within 3 months of birth to an infant in need thereof a composition comprising 0.5 to 75 g of non-digestible oligosaccharides per 100 g dry weight of the composition, wherein the non-digestible oligosaccharides comprise galacto-oligosaccharides having at least 50% of its saccharide units as galactose units.
地址 Zoetermeer NL